PL
GMAB icon

Perpetual Ltd’s Genmab GMAB Stock Holding History

Perpetual Ltd’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2M Buy
919,048
+160,545
+21% +$4.27M 0.36% 81
2026
Q1 		$20.4M Sell
758,503
-68,714
-8% -$2.06M 0.31% 83
2025
Q4 		$25.5M Buy
+827,217
New +$25.8M 0.37% 75

Other funds holding GMAB

LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
ECM
Evergreen Capital Management Bellevue, Washington $5.7B AUM 32.06% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Perpetual Ltd's GMAB Position: Q2 2026 in Review

Perpetual Ltd increased its Genmab (GMAB) stake by 21% in Q2 2026, buying an estimated $4.27M and bringing the position to 919,048 shares worth $25.2M. The position accounts for 0.36% of the portfolio, ranked #81.

Perpetual Ltd first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $25.5M in Q4 2025. 67 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Perpetual Ltd held 919,048 shares of Genmab worth $25.2M as of Q2 2026.
  • Perpetual Ltd bought 160,545 Genmab shares in Q2 2026, an estimated $4.27M.
  • Genmab made up 0.36% of Perpetual Ltd's portfolio in Q2 2026, its #81 holding.
  • Perpetual Ltd first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • Perpetual Ltd's Genmab position peaked at $25.5M in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.